A combination of modified transnasal endoscopic maxillectomy via transnasal prelacrimal recess approach with or without radiotherapy for selected sinonasal malignancies

Eur Arch Otorhinolaryngol. 2015 Oct;272(10):2933-8. doi: 10.1007/s00405-014-3248-3. Epub 2014 Aug 22.

Abstract

An external approach for resection of sinonasal tumors is associated with increased morbidity. Therefore, we employed a modified transnasal endoscopic maxillectomy combined with pre and/or postoperative radiotherapy for early stage maxillary carcinomas. It aims to evaluate our early experience with endoscopic resection of selected malignant sinonasal tumors. The medical and radiology records of patients who underwent endonasal endoscopic resection of malignant sinonasal tumors between 2008 and 2012 were retrospectively reviewed. Ten cases of selected malignant tumor were performed to resect by modified transnasal endoscopic maxillectomy. All the patients were without evidence of disease at a mean follow-up of 26.8 months. No major complications were recorded. The mean hospitalization stay was 6.6 days. In very carefully selected cases of malignant tumors, modified transnasal endoscopic maxillectomy is acceptable. The postoperative complication rate is low, cosmetic outcome is excellent and patients do not require a long hospitalization.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma / pathology
  • Carcinoma / radiotherapy
  • Carcinoma / surgery*
  • Female
  • Humans
  • Length of Stay
  • Male
  • Maxillary Sinus Neoplasms / pathology
  • Maxillary Sinus Neoplasms / radiotherapy
  • Maxillary Sinus Neoplasms / surgery*
  • Middle Aged
  • Natural Orifice Endoscopic Surgery / methods*
  • Radiotherapy, Adjuvant
  • Retrospective Studies
  • Treatment Outcome